QuidelOrtho Corporation
General ticker "QDEL" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.2B (TTM average)
QuidelOrtho Corporation follows the US Stock Market performance with the rate: 3.4%.
Estimated limits based on current volatility of 3.0%: low 26.62$, high 28.28$
Factors to consider:
- Total employees count: 6600 as of 2024
- US accounted for 56.4% of revenue in the fiscal year ended 2024-12-29
- Top business risk factors: Market competition, Failure to innovate, Geopolitical risks, Respiratory product sales fluctuations, Supply chain disruptions
- Current price 30.1% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [42.07$, 72.96$]
- 2024-12-30 to 2025-12-30 estimated range: [39.81$, 69.10$]
Short-term QDEL quotes
Long-term QDEL plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $2,997.80MM |
| Operating Expenses | $2,858.70MM |
| Operating Income | $139.10MM |
| Non-Operating Income | $-168.20MM |
| Interest Expense | $147.60MM |
| R&D Expense | $245.00MM |
| Income(Loss) | $-29.10MM |
| Taxes | $-19.00MM |
| Profit(Loss)* | $-10.10MM |
| Stockholders Equity | $5,005.90MM |
| Inventory | $577.80MM |
| Assets | $8,563.10MM |
| Operating Cash Flow | $280.20MM |
| Capital expenditure | $209.30MM |
| Investing Cash Flow | $-187.60MM |
| Financing Cash Flow | $-265.80MM |
| Earnings Per Share** | $-0.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.